77 related articles for article (PubMed ID: 24525219)
1. Evaluation of the reproducibility of a protocol for the pharmacokinetic study of breast tumors by dynamic magnetic resonance imaging.
Etxano J; García-Lallana Valbuena A; Antón Ibáñez I; Elizalde A; Pina L; García-Foncillas J; Boni V
Radiologia; 2015; 57(1):44-9. PubMed ID: 24525219
[TBL] [Abstract][Full Text] [Related]
2. Analysis of the changes induced by bevacizumab using a high temporal resolution DCE-MRI as prognostic factors for response to further neoadjuvant chemotherapy.
Etxano J; Insausti LP; Elizalde A; López Vega JM; Plazaola A; Martínez P
Acta Radiol; 2015 Nov; 56(11):1300-7. PubMed ID: 25348477
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of preoperative dynamic contrast-enhanced magnetic resonance imaging in epithelial ovarian cancer.
Lindgren A; Anttila M; Arponen O; Rautiainen S; Könönen M; Vanninen R; Sallinen H
Eur J Radiol; 2019 Jun; 115():66-73. PubMed ID: 31084761
[TBL] [Abstract][Full Text] [Related]
4. Optimizing MRI scan time in the computation of pharmacokinetic parameters (K(trans) ) in breast cancer diagnosis.
Jena A; Mehta SB; Taneja S
J Magn Reson Imaging; 2013 Sep; 38(3):573-9. PubMed ID: 23349046
[TBL] [Abstract][Full Text] [Related]
5. Role of pharmacokinetic parameters derived with high temporal resolution DCE MRI using simultaneous PET/MRI system in breast cancer: A feasibility study.
Jena A; Taneja S; Singh A; Negi P; Mehta SB; Sarin R
Eur J Radiol; 2017 Jan; 86():261-266. PubMed ID: 28027758
[TBL] [Abstract][Full Text] [Related]
6. Correlation of dynamic contrast-enhanced MRI perfusion parameters with angiogenesis and biologic aggressiveness of rectal cancer: Preliminary results.
Yeo DM; Oh SN; Jung CK; Lee MA; Oh ST; Rha SE; Jung SE; Byun JY; Gall P; Son Y
J Magn Reson Imaging; 2015 Feb; 41(2):474-80. PubMed ID: 24375840
[TBL] [Abstract][Full Text] [Related]
7. Histogram analysis of quantitative pharmacokinetic parameters on DCE-MRI: correlations with prognostic factors and molecular subtypes in breast cancer.
Nagasaka K; Satake H; Ishigaki S; Kawai H; Naganawa S
Breast Cancer; 2019 Jan; 26(1):113-124. PubMed ID: 30069785
[TBL] [Abstract][Full Text] [Related]
8. Breast cancer: early prediction of response to neoadjuvant chemotherapy using parametric response maps for MR imaging.
Cho N; Im SA; Park IA; Lee KH; Li M; Han W; Noh DY; Moon WK
Radiology; 2014 Aug; 272(2):385-96. PubMed ID: 24738612
[TBL] [Abstract][Full Text] [Related]
9. Dynamic magnetic resonance imaging of the breast: Comparison of gadobutrol vs. Gd-DTPA.
Escribano F; Sentís M; Oliva JC; Tortajada L; Villajos M; Martín A; Ganau S
Radiologia (Engl Ed); 2018; 60(1):49-56. PubMed ID: 29217300
[TBL] [Abstract][Full Text] [Related]
10. Dynamic contrast-enhanced perfusion parameters in ovarian cancer: Good accuracy in identifying high HIF-1α expression.
Lindgren A; Anttila M; Rautiainen S; Arponen O; Hämäläinen K; Könönen M; Vanninen R; Sallinen H
PLoS One; 2019; 14(8):e0221340. PubMed ID: 31437208
[TBL] [Abstract][Full Text] [Related]
11. Reproducibility of the aortic input function (AIF) derived from dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) of the kidneys in a volunteer study.
Mendichovszky IA; Cutajar M; Gordon I
Eur J Radiol; 2009 Sep; 71(3):576-81. PubMed ID: 19004588
[TBL] [Abstract][Full Text] [Related]
12. The kinetic analysis of breast cancer: An investigation of the optimal temporal resolution for dynamic contrast-enhanced MR imaging.
Matsukuma M; Furukawa M; Yamamoto S; Nakamura K; Tanabe M; Okada M; Iida E; Ito K
Clin Imaging; 2020 May; 61():4-10. PubMed ID: 31945688
[TBL] [Abstract][Full Text] [Related]
13. Dynamic contrast-enhanced MRI to characterize angiogenesis in primary epithelial ovarian cancer: An exploratory study.
Lindgren A; Anttila M; Arponen O; Hämäläinen K; Könönen M; Vanninen R; Sallinen H
Eur J Radiol; 2023 Aug; 165():110925. PubMed ID: 37320880
[TBL] [Abstract][Full Text] [Related]
14. [Relationship between parameters of dynamic contrast-enhanced MRI and clinical stage of nasopharyngeal carcinoma].
Yu X; Li F; Hu Y; Lu Q; Wang H
Zhonghua Zhong Liu Za Zhi; 2015 Aug; 37(8):597-602. PubMed ID: 26714600
[TBL] [Abstract][Full Text] [Related]
15. Optimized Fast Dynamic Contrast-Enhanced Magnetic Resonance Imaging of the Prostate: Effect of Sampling Duration on Pharmacokinetic Parameters.
Othman AE; Falkner F; Martirosian P; Schraml C; Schwentner C; Nickel D; Nikolaou K; Notohamiprodjo M
Invest Radiol; 2016 Feb; 51(2):106-12. PubMed ID: 26447494
[TBL] [Abstract][Full Text] [Related]
16. Inter- and intra-rater reproducibility of quantitative dynamic contrast enhanced MRI using TWIST perfusion data in a uterine fibroid model.
Davenport MS; Heye T; Dale BM; Horvath JJ; Breault SR; Feuerlein S; Bashir MR; Boll DT; Merkle EM
J Magn Reson Imaging; 2013 Aug; 38(2):329-35. PubMed ID: 23239041
[TBL] [Abstract][Full Text] [Related]
17. Prediction and monitoring of treatment effect using T1-weighted dynamic contrast-enhanced magnetic resonance imaging in colorectal liver metastases: potential of whole tumour ROI and selective ROI analysis.
Coenegrachts K; Bols A; Haspeslagh M; Rigauts H
Eur J Radiol; 2012 Dec; 81(12):3870-6. PubMed ID: 22944331
[TBL] [Abstract][Full Text] [Related]
18. Analysis of kinetic curve and model-based perfusion parameters on dynamic contrast enhanced MRI in breast cancer patients: Correlations with dominant stroma type.
Yim H; Kang DK; Jung YS; Jeon GS; Kim TH
Magn Reson Imaging; 2016 Jan; 34(1):60-5. PubMed ID: 26234500
[TBL] [Abstract][Full Text] [Related]
19. Associations between tumor vascularization assessed by in vivo DCE-MRI and the presence of disseminated tumor cells in bone marrow in breast cancer patients at the time of diagnosis.
Nilsen LB; Fangberget A; Geier OM; Engebraaten O; Borgen E; Olsen DR; Seierstad T
J Magn Reson Imaging; 2014 Dec; 40(6):1382-91. PubMed ID: 24470360
[TBL] [Abstract][Full Text] [Related]
20. A comparison of arterial spin labeling perfusion MRI and DCE-MRI in human prostate cancer.
Cai W; Li F; Wang J; Du H; Wang X; Zhang J; Fang J; Jiang X
NMR Biomed; 2014 Jul; 27(7):817-25. PubMed ID: 24809332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
